• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Takeda Pharmaceuticals

Evox Therapeutics completes $95.4M Series C

February 18, 2021 By Sean Whooley Leave a Comment

Evox Therapeutics announced today that it raised $95.4 million (£69.2 million) in a Series C financing round. Oxford, England-based Evox’s financing was significantly oversubscribed with high demand from both existing and new investors, according to a news release. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Funding Roundup, Pharmaceutical Tagged With: Eli Lilly & Co., evoxtherapeutics, Takeda Pharmaceuticals

Corza Medical set to take on ‘almost monopolistic’ surgical giants

February 1, 2021 By Tom Salemi

Corza Medical, a new venture forged by the financial firepower of private equity giant GTCR, is looking to become a surgical tool supplier that its executive chairman Greg Lucier says can compete with “almost monopolistic” leaders in the space. To mount the challenge, Corza acquired Surgical Specialties Corp., a supplier of surgical sutures and ophthalmic […]

Filed Under: Business/Financial News, Featured, Optical/Ophthalmic, Surgical, Vision, Wound Care Tagged With: Applied Biosystems, Corza Health, Corza Medical, Ethicon, GTCR Golder Rauner LLC, Invitrogen, Johnson & Johnson, Medtronic, Surgical Specialties, Takeda Pharmaceuticals, Thermo Fisher Scientific

European Commission scrutinizes J&J TachoSil buy

March 26, 2020 By Nancy Crotti

The European Commission said Wednesday that it has opened an in-depth investigation of  the proposed $400 million acquisition of  Takeda Pharmaceutical’s (TSE:4502;NYSE:TAK) TachoSil surgical sealant patch by Johnson & Johnson (NYSE:JNJ). The commission said it is concerned that the acquisition by J&J’s Ethicon unit may reduce competition and innovation for the supply of dual haemostatic patches, used […]

Filed Under: Business/Financial News, Featured, Hospital Care, Mergers & Acquisitions, Regulatory/Compliance, Surgical Tagged With: Ethicon, European Commission, Johnson & Johnson, Takeda Pharmaceuticals

J&J’s Ethicon buys Takeda’s TachoSil fibrin patch for $400m

May 9, 2019 By Brad Perriello

Takeda Pharmaceutical (TSE:4502;NYSE:TAK) said yesterday that it’s dealing its TachSil fibrin patch to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon for $400 million in cash. The Japanese company, which is still digesting last year’s $62 billion acquisition of Shire, said it also agreed to sell its Xiidra lifitegrast ophthalmic solution to Novartis (NYSE:NVS) for $3.4 billion, […]

Filed Under: Mergers & Acquisitions, Surgical, Wall Street Beat Tagged With: Ethicon, Johnson and Johnson, Takeda Pharmaceuticals

Takeda reaches $62B deal to buy Shire

May 8, 2018 By Sarah Faulkner

After a series of offers, Takeda (TYO:4502) said today that it reached an agreement with Shire (NSDQ:SHPG) to acquire the U.S.-based company in a deal valued at $62 billion. The merger was approved by both companies’ boards of directors, according to Takeda, and is slated to close in the first half of 2019. Takeda investors are wary of the enormous […]

Filed Under: Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: Shire Plc., Takeda Pharmaceuticals

Shire accepts $64B takeover bid from Takeda

April 25, 2018 By Fink Densford

 Shire (NSDQ:SHPG) said late yesterday it agreed to Takeda Pharmaceutical‘s (TYO:4502) reworked acquisition bid, now worth approximately $64.2 billion (GBP £46 billion). The takeover offer will now go to Shire’s shareholders for approval, having received backing from Dublin, Ireland-based Shire’s board of directors, according to a press release. Read the whole story on our sister site, […]

Filed Under: Blog Tagged With: Shire Plc., Takeda Pharmaceuticals

Report: Takeda raises $60B offer for Shire, nears prelim acquisition agreement

April 24, 2018 By Fink Densford

Takeda Pharmaceutical (TYO:4502) has sweetened its approximately $60 billion bid for Shire (NSDQ:SHPG) and is approaching a preliminary agreement for acquisition, according to a new report from Bloomberg. The deal could come to a head as early as today, according to the report, as both companies have been working on a tentative agreement and price for the […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Pharmaceutical Tagged With: Allergan, Shire Plc., Takeda Pharmaceuticals

Allergan, Takeda spar for Shire

April 19, 2018 By Brad Perriello

Allergan (NYSE: AGN) today confirmed that it’s in the running to acquire Shire (NSDQ:SHPGY), which rejected a $63 billion offer from Takeda Pharmaceutical (TYO:4502). Dublin-based Allergan, which is in the process of slashing 1,400 jobs from its payroll and exploring “strategic actions,” said there’s no guarantee it will make an offer for Shire. Get the full story at our sister […]

Filed Under: Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: Allergan, Spire Corp., Takeda Pharmaceuticals

Fine-tuning formulation with Fluid Imaging Technologies’ FlowCam

April 6, 2018 By Sarah Faulkner

After seven people died in 2013 from serious allergic reactions to Omontys, an injectable anemia drug marketed by Takeda Pharmaceutical (TYO:4502) and Affymax, the companies recalled the product and regulators launched an investigation to find out the cause of such an unexpected rate of anaphylaxis. Omontys was made and cleared in a single-use vial and a multi-use […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Imaging, Pharmaceutical, Recalls, Regulatory/Compliance Tagged With: fluidimagingtechnologies, Mayo Clinic, Takeda Pharmaceuticals

Denali inks collab with Takeda to help Alzheimer’s drugs get into the brain

January 5, 2018 By Sarah Faulkner

Denali Therapeutics (NSDQ:DNLI) has landed a strategic partnership with Takeda Pharmaceutical (TYO:4502) to develop and commercialize three of its product candidates for neurodegenerative diseases. The deal includes Denali’s preclinical Alzheimer’s projects, among other undisclosed candidates, which make use of the company’s antibody transport vehicles, or ATVs, to penetrate the blood-brain barrier. Get the full story at our sister […]

Filed Under: Funding Roundup, Neurological, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: denalitherapeutics, Takeda Pharmaceuticals

Takeda, Portal Instruments ink $100m deal to combine biologics and needle-free drug delivery

November 7, 2017 By Sarah Faulkner

Takeda Pharmaceutical (TYO:4502) and Portal Instruments said today that the pair inked a collaboration to develop and commercialize Portal’s needle-free drug delivery device with Takeda’s biologic medicines. The first development program is slated to combine Takeda’s monoclonal antibody for adults with moderately- to severely-active ulcerative colitis or Crohn’s disease with Portal’s technology. The investigational therapy is currently administered […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: portal instruments, Takeda Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS